Xiaocheng Charlie Dong (X Charlie Dong)

Publication Activity (10 Years)

Years Active: 2018-2022
Publications (10 Years): 7

Top Topics

Transforming Growth Factor

Bioinformatics Analysis

Top Venues

Nature medicine

Hepatology (Baltimore, Md.)

Cell death & disease

This page only lists publications with an associated author ORCID identifier.

Publications

Kushan Chowdhury, Menghao Huang, Hyeong-Geug Kim, Xiaocheng Charlie Dong
Sirtuin 6 protects against hepatic fibrogenesis by suppressing the YAP and TAZ function. FASEB journal : official publication of the Federation of American Societies for Experimental Biology 36 (10) (2022)
Xiaocheng Charlie Dong, Kushan Chowdhury, Menghao Huang, Hyeong Geug Kim
Signal Transduction and Molecular Regulation in Fatty Liver Disease. Antioxidants & redox signaling 35 (9) (2021)
Lin Xu, Xinge Zhang, Yue Xin, Jie Ma, Chenyan Yang, Xi Zhang, Guoqing Hou, Xiaocheng Charlie Dong, Zhaoli Sun, Xiwen Xiong, Xuan Cao
Depdc5 deficiency exacerbates alcohol-induced hepatic steatosis via suppression of PPARα pathway. Cell death & disease 12 (7) (2021)
Xiaocheng Charlie Dong
A closer look at the mysterious HSD17B13. Journal of lipid research 61 (11) (2020)
Menghao Huang, Hyeong Geug Kim, Xiaolin Zhong, Chuanpeng Dong, Brian Zhang, Zhigang Fang, Yang Zhang, Xiaoyu Lu, Romil Saxena, Yunlong Liu, Chi Zhang, Suthat Liangpunsakul, Xiaocheng Charlie Dong
Sestrin 3 Protects Against Diet-Induced Nonalcoholic Steatohepatitis in Mice Through Suppression of Transforming Growth Factor β Signal Transduction. Hepatology (Baltimore, Md.) 71 (1) (2019)
Rongya Tao, Caixia Wang, Oliver Stöhr, Wei Qiu, Yue Hu, Ji Miao, Xiaocheng Charlie Dong, Sining Leng, Margaret Stefater, Nicholas Stylopoulos, Lin Lin, Kyle D Copps, Morris F White
Inactivating hepatic follistatin alleviates hyperglycemia. Nature medicine 24 (7) (2018)
Xiaocheng Charlie Dong
SCP4: A Small Nuclear Phosphatase Having a Big Effect on FoxOs in Gluconeogenesis. Diabetes 67 (1) (2018)